1) Encapsulation Technology of Perfumes/Fragrances: A research Report

The purpose of this research report is to commercialize this technical paper to the interested clients who are working in this technological field. Technical know how disclosed in the various prior arts, disclosed in this report, are the mile stones for the pipe line products coming in this field. The key players, their products, competitors and the scope of future development is highlighted to guide the researchers. This comprehensive study not only helps ITAG’s future clients to understand the area of expertise in ITAG, but also provides a strong platform to invent and reinvent and penetrate the knowledge driven technological market. The IP maps in different technological area are of prime importance to the researchers as well as for the business analysis process.

Click Here to view Sample Report

 

2) Use of opioid antagonists for the treatment of  GI associated side effects

The report entitled “Opioid antagonists for the treatment of GI associated disorder” highlights an effective research methodology while analyzing the technology- existing and new key players, competitors profile, their technology trend, pipeline products, less practiced research area and further scope of research. This report further explores the following:

1. Opioid antagonist
2. Type of Opioid
3. Nature of formulation (Combination/Single form)
4. Intended application
5. Primary disease
6. Major assignees involved
7. Major technologies involved
8. Major IPC’s
9. Major Focus of patents
10. Major application areas
11. Mechanism of action of opioid antagonist

The in depth analysis of the existing IP in this field, provides a land mark in the drug development using opioid antagonist for the gastrointestinal disorder. Key players, maximum of which are independent inventors are coming up with new clinical exposure in this field of research. This report proved to be an ideal resource for all who are either involved in research work in this field or in the way of commercializing their products using opioid antagonist as an active ingredient.

 

Click Here to view Sample Report